A comparison between extract products of Magnolia officinalis On memory impairment and amyloidogenesis in a transgenic mouse model of Alzheimer's disease

Biomolecules and Therapeutics

Volumn 20, Issue 3, 2012, Pages 332-339

  Lee, Young Jung ^a,b,c   Choi, Dong Young ^a,b,c   Han, Sang Bae ^a,b,c   Kim, Young Hee ^d   Kim, Ki Ho ^d   Seong, Yeon Hee ^c   Oh, Ki Wan ^a,b,c   Hong, Jin Tae ^a,b,c  

^a Research Institute of Pharmaceutical Sciences   (South Korea)

^b Medical Research Center   (South Korea)

^c Chungbuk National University   (South Korea)

^d Bioland Ltd   (South Korea)

Author keywords

Alzheimer's disease; Magnolia; Natural product; Tg2576

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; MAGNOLIA OFFICINALIS EXTRACT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; TRANSGENIC MOUSE;

EID: 84862662586     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2012.20.3.332     Document Type: Article

References (53)

1. Blennow, K., de Leon, M. J. and Zetterberg, H. (2006) Alzheimer's disease. Lancet 368, 387-403.
2. Castellani, R. J., Zhu, X., Lee, H. G., Moreira, P. I., Perry, G. and Smith, M. A. (2007) Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? Expert Rev. Neurother. 7, 473-485.
3. Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V., Hyman, B. T., Younkin, S. G. and Hsiao, K. K. (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271-276.
4. Chen, C. L., Chang, P. L., Lee, S. S., Peng, F. C., Kuo, C. H. and Chang, H. T. (2007) Analysis of magnolol and honokiol in biological fluids by capillary zone electrophoresis. J. Chromatogr. A 1142, 240-244.
5. Choi, D. Y., Lee, J. W., Lin, G., Lee, Y. K., Lee, Y. H., Choi, I. S., Han, S.B., Jung, J. K., Kim, Y. H., Kim, K. H., Oh, K. W., Hong, J. T. and Lee, M. S. (2012a) Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway. Neurochem. Int. 60, 68-77.
6. Choi, D. Y., Lee, J. W., Peng, J., Lee, Y. J., Han, J. Y., Lee, Y. H., Choi, I. S., Han, S. B., Jung, J. K., Lee, W. S., Lee, S. H., Kwon, B. M., Oh, K. W. and Hong, J. T. (2012b) Obovatol improves cognitive functions in animal models for Alzheimer's disease. J. Neurochem. 120, 1048-1059.
7. Choi, I. S., Lee, Y. J., Choi, D. Y., Lee, Y. K., Lee, Y. H., Kim, K. H., Kim, Y. H., Jeon, Y. H., Kim, E. H., Han, S. B., Jung, J. K., Yun, Y. P., Oh, K. W., Hwang, D. Y. and Hong, J. T. (2011) 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 27, 127-141.
8. Choi, J. H., Ha, J., Park, J. H., Lee, J. Y., Lee, Y. S., Park, H. J., Choi, J. W., Masuda, Y., Nakaya, K. and Lee, K. T. (2002) Costunolide triggers apoptosis in human leukemia U937 cells by depleting intracellular thiols. Jpn. J. Cancer Res. 93, 1327-1333.
9. Cole, S. L. and Vassar, R. (2007) The Alzheimer's disease beta-secretase enzyme, BACE1. Mol. Neurodegener. 2, 22.
10. Cui, H. S., Huang, L. S., Sok, D. E., Shin, J., Kwon, B. M., Youn, U. J. and Bae, K. (2007) Protective action of honokiol, administered orally, against oxidative stress in brain of mice challenged with NMDA. Phytomedicine 14, 696-700.
11. De Strooper, B. and Annaert, W. (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113, 1857-1870.
12. Dikalov, S., Losik, T. and Arbiser, J. L. (2008) Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem. Pharmacol. 76, 589-596.
13. Duff, K. and Suleman, F. (2004). Transgenic mouse models of Alzheimer's disease: how useful have they been for therapeutic development? Brief. Funct. Genomic. Proteomic. 3, 47-59.
14. Ferri, C. P., Sousa, R., Albanese, E., Ribeiro, W. S. and Honyashiki, M. (2009) World Alzheimer Report 2009 Executive Summary. (M. Prince and J. Jackson, Eds.), pp. 1-22. Alzheimer's Disease International London.
15. Fujita, S. and Taira, J. (1994) Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102.Free Radic. Biol. Med. 17, 273-277.
16. Golde, T. E., Dickson, D. and Hutton, M. (2006) Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease. Curr. Alzheimer Res. 3, 421-430.
17. Hoi, C. P., Ho, Y. P., Baum, L. and Chow, A. H. (2010) Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother. Res. 24, 1538-1542.
18. Hou, Y. C., Chao, P. D. and Chen, S. Y. (2000) Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats. Am. J. Chin. Med. 28, 379-384.
19. Hsiao, K. (1998) Transgenic mice expressing Alzheimer amyloid precursor proteins. Exp. Gerontol. 33, 883-889.
20. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
21. Ito, K., Iida, T., Ichino, K., Tsunezuka, M., Hattori, M. and Namba, T. (1982) Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem. Pharm. Bull. (Tokyo) 30, 3347-3353.
22. Iwasaki, K., Wang, Q., Seki, H., Satoh, K., Takeda, A., Arai, H. and Sasaki, H. (2000) The effects of the traditional chinese medicine, Banxia Houpo Tang (Hange-Koboku To) on the swallowing reflex in Parkinson's disease. Phytomedicine 7, 259-263.
23. Janus, C. and Westaway, D. (2001) Transgenic mouse models of Alzheimer's disease. Physiol. Behav. 73, 873-886.
24. Kang, J. S., Lee, K. H., Han, M. H., Lee, H., Ahn, J. M., Han, S. B., Han, G., Lee, K., Park, S. K. and Kim, H. M. (2008) Antiinflammatory activity of methanol extract isolated from stem bark of Magnolia kobus. Phytother. Res. 22, 883-888.
25. Kong, C. W., Tsai, K., Chin, J. H., Chan, W. L. and Hong, C. Y. (2000) Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock 13, 24-28.
26. Kuribara, H., Stavinoha, W. B. and Maruyama, Y. (1998) Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J. Pharm. Pharmacol. 50, 819-826.
27. Lee, J. W., Lee, Y. K., Lee, B. J., Nam, S. Y., Lee, S. I., Kim, Y. H., Kim, K. H., Oh, K. W. and Hong, J. T. (2010) Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. Pharmacol. Biochem. Behav. 95, 31-40.
28. Lee, M., Kwon, B. M., Suk, K., McGeer, E. and McGeer, P. L. (2012a) Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage. J. Neuroimmune. Pharmacol. 7, 173-186.
29. Lee, Y. J., Choi, D. Y., Choi, I. S., Kim, K. H., Kim, Y. H., Kim, H. M., Lee, K., Cho, W. G., Jung, J. K., Han, S. B., Han, J. Y., Nam, S. Y., Yun, Y. W., Jeong, J. H., Oh, K. W. and Hong, J. T. (2012b) Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models. J. Neuroinflammation 9, 35.
30. Lee, Y. J., Choi, D. Y., Han, S. B., Kim, Y. H., Kim, K. H., Hwang, B. Y., Kang, J. K., Lee, B. J., Oh, K. W. and Hong, J. T. (2012c) Inhibitory Effect of Ethanol Extract of Magnolia officinalis on Memory Impairment and Amyloidogenesis in a Transgenic Mouse Model of Alzheimer's Disease via Regulating β-Secretase Activity. Phytother. Res. [Epub ahead of print].
31. Lee, Y. J., Choi, D. Y., Lee, Y. K., Lee, Y. M., Han, S. B., Kim, Y. H., Kim, K. H., Nam, S. Y., Lee, B. J., Kang, J. K., Yun, Y. W., Oh, K. W. and Hong, J. T. (2012d) 4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer' disease via regulation of β-secretase activity. J. Alzheimers Dis. 29, 677-690.
32. Lee, Y. J., Choi, I. S., Park, M. H., Lee, Y. M., Song, J. K., Kim, Y. H., Kim, K. H., Hwang, D. Y., Jeong, J. H., Yun, Y. P., Oh, K. W., Jung, J. K., Han, S. B. and Hong, J. T. (2011a) 4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. Free Radic. Biol. Med. 50, 66-77.
33. Lee, Y. J., Lee, Y. M., Lee, C. K., Jung, J. K., Han, S. B. and Hong, J. T. (2011b) Therapeutic applications of compounds in the Magnolia family. Pharmacol. Ther. 130, 157-176.
34. Lee, Y. K., Choi, I. S., Ban, J. O., Lee, H. J., Lee, U. S., Han, S. B., Jung, J. K., Kim, Y. H., Kim, K. H., Oh, K. W. and Hong, J. T. (2011c) 4-O-methylhonokiol attenuated β-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase. J. Nutr. Biochem. 22, 476-486.
35. Lee, Y. K., Yuk, D. Y., Kim, T. I., Kim, Y. H., Kim, K. T., Kim, K. H., Lee, B. J., Nam, S. Y. and Hong, J. T. (2009) Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity. J. Nat. Med. 63, 274-282.
36. Lin, S. P., Tsai, S. Y., Lee Chao, P. D., Chen, Y. C. and Hou, Y. C. (2011) Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats. Planta Med. 77, 1800-1805.
37. Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A. and Tang, J. (2000) Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA 97, 1456-1460
38. Lin, Y. R., Chen, H. H., Ko, C. H. and Chan, M. H. (2007) Effects of honokiol and magnolol on acute and inflammatory pain models in mice. Life Sci. 81, 1071-1078.
39. Lin, Y. R., Chen, H. H., Ko, C. H. and Chan, M. H. (2006) Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur. J. Pharmacol. 537, 64-69.
40. Luo, L., Nong Wang, J., Kong, L. D., Jiang, Q. G. and Tan, R. X. (2000) Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. J. Ethnopharmacol. 73, 277-281.
41. Matsui, N., Takahashi, K., Takeichi, M., Kuroshita, T., Noguchi, K., Yamazaki, K., Tagashira, H., Tsutsui, K., Okada, H., Kido, Y., Yasui, Y., Fukuishi, N., Fukuyama, Y. and Akagi, M. (2009) Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res. 1305, 108-117.
42. Morris, R. (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60.
43. Munroe, M. E., Arbiser, J. L. and Bishop, G. A. (2007) Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J. Immunol. 179, 753-763.
44. Selkoe, D. J. (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-453.
45. Song, W. Z., Cui, J. F. and Zhang, G. D. (1989) Studies on the medicinal plants of Magnoliaceae tu-hou-po of Manglietia. Yao. Xue. Xue. Bao. 24, 295-299.
46. Tachikawa, E., Takahashi, M. and Kashimoto, T. (2000) Effects of extract and ingredients isolated from Magnolia obovata thunberg on catecholamine secretion from bovine adrenal chromaffin cells. Biochem. Pharmacol. 60, 433-440.
47. Tsai, T. H., Chou, C. J. and Chen, C. F. (1996) Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection. J. Pharm. Pharmacol. 48, 57-59.
48. Watanabe, K., Watanabe, H., Goto, Y., Yamaguchi, M., Yamamoto, N. and Hagino, K. (1983) Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects. Planta Med. 49, 103-108.
49. Weeks, B. S. (2009) Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med. Sci. Monit. 15, RA256-262.
50. Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G. and Ashe, K. H. (2002) The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22, 1858-1867.
51. Xu, Q., Yi, L. T., Pan, Y., Wang, X., Li, Y. C., Li, J. M., Wang, C. P. and Kong, L. D. (2008) Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog. Neuropsychopharmacol. Biol. Psychiatry. 32, 715-725.
52. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashier, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., Carter, D. B., Tomasselli, A. G., Parodi, L. A., Heinrikson, R. L. and Gurney, M. E. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537.
53. Zhou, H. Y., Shin, E. M., Guo, L. Y., Youn, U. J., Bae, K., Kang, S. S., Zou, L. B. and Kim, Y. S. (2008) Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation. Eur. J. Pharmacol. 586, 340-349.